Booster Shots Of Pfizer’s COVID-19 Vaccine Lead To Higher Levels Of Protective Antibodies, Early Data Suggest

Bloomberg (8/16, Griffin, Langreth) reports Pfizer and partner BioNTech “submitted early-stage data to U.S. regulators showing that a third dose of their Covid-19 vaccine led to higher levels of protective antibodies when given eight to nine months after...